Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVPH | ZTS | TAK | UTHR | NBIX |
| Company | Reviva Pharmaceuticals Hldg Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 1.1900 | 166.86 | 15.08 | 307.15 | 112.26 |
| High | 1.2400 | 170.93 | 15.22 | 320.81 | 115.00 |
| Low | 1.1400 | 166.76 | 15.08 | 306.11 | 112.00 |
| Last | 1.1500 | 170.37 | 15.17 | 315.91 | 113.04 |
| Change | -0.0300 | +3.12 | +0.17 | +8.23 | +0.38 |
| % Change | -2.54% | +1.87% | +1.13% | +2.67% | +0.34% |
| Volume | 652,100 | 3,296,800 | 1,575,000 | 740,100 | 1,650,700 |
| 20-Day Average Volume | 1,329,380 | 4,024,800 | 1,451,890 | 603,720 | 1,782,370 |
| Previous Close | 1.1800 | 167.25 | 15.00 | 307.68 | 112.66 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.5750 | 166.05 | 14.14 | 343.60 | 116.42 |
| 20-Day Raw Stochastic | 1.00% | 75.78% | 97.54% | 13.90% | 12.83% |
| 20-Day Relative Strength | 34.45% | 53.07% | 73.21% | 36.23% | 34.40% |
| Weighted Alpha | -66.40 | -5.91 | +9.24 | +16.01 | -23.17 |
| Today's Opinion | 8% Sell | 64% Sell | 40% Buy | 72% Sell | 56% Sell |
| Previous Opinion | 8% Sell | 64% Sell | 40% Buy | 56% Sell | 56% Sell |
| Last Month's Opinion | 100% Buy | 40% Sell | 40% Sell | 8% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -20.14% since 02/28/25 | +1.87% since 02/28/25 | +5.27% since 02/28/25 | -1.29% since 02/28/25 | -4.78% since 02/28/25 |
| Low | 1.1400 on 03/07/25 | 165.22 on 03/05/25 | 14.55 on 03/03/25 | 305.00 on 03/06/25 | 110.25 on 03/04/25 |
| High | 1.4700 on 03/03/25 | 174.80 on 03/04/25 | 15.22 on 03/07/25 | 320.81 on 03/07/25 | 119.00 on 03/03/25 |
| 1-Month | |||||
| %Chg | -44.71% since 02/07/25 | -0.62% since 02/07/25 | +12.12% since 02/07/25 | -9.15% since 02/07/25 | -7.81% since 02/07/25 |
| Low | 1.1400 on 03/07/25 | 154.32 on 02/18/25 | 13.19 on 02/12/25 | 305.00 on 03/06/25 | 110.25 on 03/04/25 |
| High | 2.1400 on 02/10/25 | 174.84 on 02/11/25 | 15.22 on 03/07/25 | 383.51 on 02/19/25 | 125.93 on 02/10/25 |
| 3-Month | |||||
| %Chg | -30.30% since 12/06/24 | -3.45% since 12/06/24 | +10.49% since 12/06/24 | -14.54% since 12/06/24 | -11.78% since 12/06/24 |
| Low | 1.1400 on 03/07/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 305.00 on 03/06/25 | 110.25 on 03/04/25 |
| High | 4.2800 on 12/09/24 | 181.85 on 12/13/24 | 15.22 on 03/07/25 | 383.51 on 02/19/25 | 154.61 on 01/30/25 |
| 6-Month | |||||
| %Chg | -14.81% since 09/06/24 | -9.97% since 09/06/24 | +2.43% since 09/06/24 | -8.60% since 09/06/24 | -5.93% since 09/06/24 |
| Low | 0.8820 on 11/11/24 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 305.00 on 03/06/25 | 110.25 on 03/04/25 |
| High | 4.2800 on 12/09/24 | 200.33 on 09/19/24 | 15.22 on 03/07/25 | 417.82 on 11/08/24 | 154.61 on 01/30/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 39,460 | 74,893,208 | 47,728,484 | 13,818,521 | 11,232,654 |
| Shares Outstanding, K | 33,441 | 447,792 | 3,181,899 | 44,912 | 99,704 |
| Annual Sales | 0 | 9,256,000,000 | 29,419,960,000 | 2,877,400,000 | 2,355,300,000 |
| Annual Net Income | -39,260,000 | 2,486,000,000 | 994,060,000 | 1,195,100,000 | 341,300,000 |
| Last Quarter Sales | 0 | 2,317,000,000 | 7,511,170,000 | 735,900,000 | 627,700,000 |
| Last Quarter Net Income | -8,370,000 | 581,000,000 | 156,180,000 | 301,300,000 | 103,100,000 |
| 60-Month Beta | -0.09 | 0.94 | 0.46 | 0.64 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 11/14/24 | 1.40 on 02/13/25 | 0.42 on 01/30/25 | 6.19 on 02/26/25 | 1.00 on 02/06/25 |
| Latest Earnings Date | 04/21/25 | 05/01/25 | 02/06/25 | 02/26/25 | 02/06/25 |
| Most Recent Dividend | N/A | 0.500 on 01/21/25 | 0.267 on 09/30/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/21/25 | 09/30/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 28.21 | 10.59 | 12.64 | 34.60 |